Photo of Moderna, Inc.

Moderna, Inc.

  • National Medal of Technology and Innovation
  • Medicine

For saving millions of lives around the world by harnessing mRNA vaccine technology to combat a global pandemic. In 2020, Moderna rapidly developed and deployed a COVID-19 mRNA vaccine that was essential to ending the COVID-19 pandemic, opening new frontiers in immunology and advancing America’s leadership in research innovation.

Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the Company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.

Moderna’s mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines.

Arati Prabhakar, Ph.D., Director of the White House Office of Science and Technology Policy (OSTP), awards Moderna Inc. representatives Noubar Afeyan (C) and Hamilton Bennett (R) the National Medal of Technology and Innovation during an awards ceremony at the Eisenhower Executive Office Building in Washington, DC, January 3, 2025. Photo by Ryan K. Morris